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Abstract
Background: Typhoid, which is caused by Salmonella enterica serovar Typhimurium, remains a major health
concern worldwide. Multidrug-resistant strains of Salmonella have emerged which exhibit increased survivability
and virulence, thus leading to increased morbidity. However, little is known about the protective immune response
against this microorganism. The outer membrane protein (Omp)A of bacteria plays an important role in
pathogenesis.
Results: We purified OmpA from S. enterica serovar Typhimurium (OmpA-sal) and characterized the role of OmpA-
sal in promoting adaptive and innate immune responses. OmpA-sal functionally activated bone marrow-derived
dendritic cells by augmenting expression of CD80, CD86, and major histocompatibility complex classes I and II.
Interestingly, OmpA-sal induced production of interferon-g from T cells in mixed lymphocyte reactions, thus
indicating Th1-polarizing capacity. The expression of surface markers and cytokine production in dendritic cells was
mediated by the TLR4 signaling pathway in a TLR4 Knock-out system.
Conclusions: Our findings suggest that OmpA-sal modulates the adaptive immune responses to S. enterica serovar
Typhimurium by activating dendritic cells and driving Th1 polarization, which are important properties to consider
in the development of effective S. enterica serovar Typhimurium vaccines and immunotherapy adjuvant.
Background
Dendritic cells (DCs) are professional antigen-presenting
cells (APCs) that play key roles in the regulation of
immune responses to a variety of antigens and immune
sentinels as initiators of T cell responses against microbial
pathogens [1-3]. In addition, during inflammation or infec-
tion, DCs are mobilized in and out of the peripheral tis-
sues. Activated DCs are targeted to secondary lymphoid
organs and toward T cell activation by antigen presenta-
tion [4,5]. DCs can capture degraded bacteria or protein of
bacteria and present their antigens on major histocompat-
ibility complex (MHC) class molecules to T cells [6]. As a
result, an adaptive immune response that specifically tar-
gets bacteria-derived antigens is initiated. Maturing DCs
then migrate to the lymphoid organs, where they activate
naïve T cells by stimulating antigenic peptide-presenting
MHC type I and II receptors and their co-stimulatory
molecules [7]. Therefore, DCs provide a link between
innate and adaptive immune responses.
Salmonella species cause typhoid fever and gastroen-
teritis in humans and pose a global threat to human
health [8]. Salmonella also infect broad array of animals,
resulting in diseases ranging from gastroenteritis to life-
threatening systemic infections [9,10]. A recent report
has shown that Salmonella enterica serovar Typhimur-
ium is a bacterial pathogen capable of interfering with
DC functions, and causes a typhoid-like disease in mice
[11]. It has also been reported that the effect of selec-
tively reduced intracellular proliferation of S. enteria ser-
ovar Typhimurium within APCs limits both antigen
presentation and development of a rapid CD8 T cell
response [12]. Outer membrane protein (Omp) from
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bute to confers protection against typhod.
However, it is still not known if hosts mount protective
immune responses against S. enterica serovar Typhimur-
ium, thus understanding how the immune system
responds to these bacteria is essential for the development
of an effective S. enterica serovar Typhimurium vaccine.
In this study, we determined the effects of a non-
cytotoxic concentration of purified outer membrane
protein A from S. enterica serovar Typhimurium
(OmpA-sal) on the maturation and function of DCs.
Our findings suggest, for the first time, that exposure to
OmpA-sal induces phenotypic and functional matura-
tion of DCs. Interestingly, exposure to OmpA-sal
induced the activation of ERK1/2 and p38 MAPK via
TLR4. The findings presented herein suggest that
OmpA-sal induces activation of DCs and initiates an
adaptive immune response by polarizing T-cell develop-
ment to a Th1 response, information which will prove
crucial in the development of a S. enterica serovar
Typhimurium vaccine.
Results
OmpA-sal induces DC maturation
We purified OmpA-sal from E. coli and assessed its cyto-
toxicity on DCs because the purified OmpA-sal was
derived from S. enterica serovar Typhimurim. DCs were
treated with various concentrations of OmpA-sal for
24 h. There were no statistically significant differences in
the percentages of dead cells in DC cultures exposed to
as much as 800 ng/ml of OmpA-sal, the concentration at
which cell death was detected by annexin V/PI staining
(Fig. 1A). This indicated that our recombinant OmpA-sal
was not cytotoxic to DCs and did not contain amounts of
endotoxin that would interfere with our studies using
concentrations < 400 ng/ml. To determine the effects of
OmpA-sal on the maturation of sentinel DCs into effec-
tor DCs, BM-derived DCs were cultured with GM-CSF
and IL-4 for 6 days under standard conditions, followed
by 1 day in the presence of 100, 200, and 400 ng/ml of
O m p A - s a l .L P Sw a su s e da sap o s i t i v ec o n t r o l .T h e
resulting populations of DCs were analyzed by flow cyto-
metry for expression of co-stimulatory molecules
involved in T cell activation. OmpA-sal-treated DCs had
increased expression of DC maturation co-stimulatory
markers (DC80, CD86, MHC class I, and MHC class II;
Fig 1B). Interestingly, the expression of CD86 and MHC
class II by OmpA-sal-treated DCs was higher than LPS-
treated DCs. These results indicated that OmpA-sal
induces DC maturation in a dose-dependent manner.
OmpA-sal reduces the endocytic activity of DCs
Immature DCs are efficient in the capture and endocy-
tosis of antigens. These cells can internalize large
amounts of antigen through each fluid-phase uptake via
macropinocytosis and receptor-mediated uptake. How-
ever, in the case of mature DCs, the capacity to capture
antigen and confer potent co-stimulatory activity for
T cells is decreased [13]. We investigated whether
OmpA-sal-treated DCs had reduced endocytic activity
characteristic of functionally mature DCs. As shown in
Fig. 2A, the percentage of double-positive cells was
lower in the LPS-treated DCs than in the untreated
DCs. Similarly, the percentage of double-positive cells
was lower in the OmpA-sal-treated DCs compared with
untreated DCs. These data show that the OmpA-sal-
treated DCs had reduced endocytic activity, which indi-
cates functional maturity.
OmpA-sal increases the number of IL-12-producing DCs,
but not IL-10
APC, such as DCs, have been shown to direct Th1
development by production of IL-12 [14]. The effector
factors that drive the development of Th1- and Th2-
type T cells are IL-12 from DCs and IFN-g or IL-4 from
T cells. We determined whether OmpA-sal induced dif-
ferentiation of Th1 subsets, and IL-12-producing DCs
were analyzed by flow cytometry and ELISA. We also
investigated the production of both intracellular IL-
12p40p70 and bioactive IL-12p70 in OmpA-sal-treated
DCs. As shown in Fig. 2B, OmpA-sal treatment of DCs
increased the percentage of IL-12-producing cells com-
pared with the results obtained for untreated DCs. Next,
we investigated the production of IL-10, a pleoiotropic
cytokine known to have inhibitory effects on the acces-
sory functions of DCs, which appears to play a role in
Th2 immune responses. The production of IL-10 was
detectable similar to that of negative controls (Fig. 2C).
OmpA-sal-treated DCs enhances Th1 polarization and IFN-
g production
To determine whether or not OmpA-sal-treated DCs sti-
mulate CD4
+ T cell activation, we stimulated DCs with
400 ng/ml of OmpA-sal for 24h and performed an allo-
geneic mixed-lymphocyte reaction. CD4
+ splenic T cells
from BALB/c mice were co-cultured with OmpA-sal-
treated DCs derived from C57BL/6 mice. The OmpA-
sal-treated DCs induced an advanced rate of T-cell
proliferation compared to the untreated control DCs
(Fig. 3A). In addition, we determined the cytokine pro-
duction of CD4
+ T cells stimulated by OmpA-sal-treated
DCs. As shown in Fig. 3B, allogeneic T cells primed with
OmpA-sal-treated DCs produced a Th1 cytokine profile
that included large amounts of IFN-g and low amounts
of IL-4. These data suggest that OmpA-sal enhances the
immunostimulatory capacity of DCs to stimulated
T cells. Moreover, we investigated whether cosignaling
via CD80 and/or CD86 enhances Th1 response, we
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production. These data suggested that both CD80 and
CD86 are essential for the Th1 response of OmpA-sal
treated DCs.
OmpA-sal induces DC maturation by TLR4 signaling
Toll-like receptors (TLRs) link innate and adaptive
immune responses [15]. The DC response to TLR ligands
depends on the activation of mitogen-activated protein
kinases (MAPKs), including ERK1/2, JNK1/2, and p38
MAPK [16]. We determined the effects of OmpA-sal on
TLRs and the MAPK signaling pathway. DCs were trea-
ted with 400 ng/ml of OmpA-sal and TLR activation was
measured by real-time quantitative reverse transcription-
PCR and phophorylation-specific Western blotting. The
level of TLR4 mRNA was significantly higher in OmpA-
sal-treated DCs than in untreated control DCs, but there
was no change in TLR2 mRNA (Fig. 4A). Moreover,
OmpA-sal enhanced the phosphorylation of ERK1/2 and
p38 MAPK in DCs, but not JNK1/2 (Fig. 4B). To confirm
whether or not the maturation of DCs by OmpA-sal was
mediated by a TLR4-related signaling pathway, we iso-
l a t e dD C sf r o mT L R 2a n dT L R 4k n o c k - o u tm i c e ,t h e n
measured IL-12 production in DCs by OmpA-sal treat-
ment. The inducing effect of OmpA-sal on IL-12 produc-
tion was completely inhibited by TLR4
-/- DCs, but it had
no effect on TLR2
-/- DCs (Fig. 4C). Moreover, we
demonstrated that OmpA-sal-treated TLR4
-/-DCs had no
increased expression of DC maturation co-stimulatory
markers (DC80, CD86, MHC class I, and MHC class II;
Fig 4D). These results indicate that the activation and
maturation of DCs by OmpA-sal is involved in TLR4
signaling.
Discussion
We have shown that OmpA-sal, a major virulence factor
of S. enterica serovar Typhimurium, is a highly immu-
nogenic protein that induces Th1 polarization of T cells
by DC maturation. Some of the Omps from bacteria
induce DC maturation and regulate Th1/Th2 immune
Figure 1 OmpA-sal is not cytotoxic and induces the expression of co-stimulatory molecules in DCs. BM-DCs were cultured for 24 h in the
presence of 200 ng/ml of LPS or 100, 200, 400, and 800 ng/ml of OmpA-sal and analyzed by flow cytometry. The DCs were stained with annexin
V and PI. The percentage of positive cells is indicated (A). The cells were gated to exclude CD11c
+ cells. Medium, untreated control; LPS, positive
control. DCs were stained with anti-CD80, anti-CD86, anti-MHC class I, and anti-MHC class II molecules (B). The data are representative of three
experiments that yielded similar results.
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the Omp of Salmonella as potential vaccine candidates,
diagnostic antigens, and virulence factors [20]. However,
the molecular mechanisms of the involvement of DCs
and T cells in the immune responses still unknown. The
lack of understanding of protective immunity against S.
enterica serovar Typhimurium has hindered the devel-
opment of an efficacious vaccine. In this study, we
found that OmpA-sal induces activation and maturation
of DCs, as demonstrated by the high expression of co-
stimulatory and MHC class molecules on cell surfaces
and reduced endocytic activity. In addition, OmpA-sal-
treated DCs induced primary T cell stimulatory activity
in an allogeneic mixed lymphocyte reaction and elicited
Th1 polarization through high levels of IFN-g and low
levels of IL-4. We have also shown in the current study
that various concentrations of OmpA-sal induce high
expression of CD80, CD86, MHC class I, and MHC
class II in DCs. Moreover, OmpA-sal-treated DCs
produced high levels of IL-12, but not IL-10. These data
suggest that OmpA-sal strongly induces activation and
maturation of DCs, and as a result DCs transmit
OmpA-sal to the adaptive immune response. Successful
induction of an adaptive immune response is character-
ized based on which antigen is presented, the dose, and
the duration of presentation [21-23]. In the case of anti-
gen recognition, an intracellular/extracelluar signaling
cascade leads to activation of APCs, which in turn pro-
motes further activation of DCs and activated T cells,
and results in proliferation of T cells and their differen-
tiation into effector T cells [5]. Accordingly, T cell pro-
liferation in mixed lymphocyte reactions is important
for efficient induction of an adaptive immune response
by interaction between DCs and T cells. In the current
study, we showed that OmpA-sal remarkably stimulates
T cell proliferation and IFN-g production, which is a
key cytokine of Th1 polarization through the increase in
IL-12 production by DCs. These findings indicate that
Figure 2 Treatment of OmpA-sal decreases endocytic capacities of DCs and induces production of IL-12.O nd a y6 ,t h ec e l l sw e r e
cultured at standard conditions for another 24 h in the presence of 200 ng/ml of LPS or 100, 200, and 400 ng/ml of OmpA-sal and harvested,
and stained with a PE-conjugated anti-CD11c
+ antibody. Endocytic capacity at 37°C or 4°C was assessed by dextran-FITC uptake (A). The
percentage of positive cells is indicated for each condition and is representative of the data of three separate experiments (B). Analysis of IL-
12p70 and IL-10 cytokine production in magnetic bead-purified DCs by ELISA (C). The data are the means and standard deviation of three
experiments. *p < 0.05, **p < 0.01 vs. untreated DCs.
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induce the Th1 immune response by DC maturation
and IL-12 production.
We also provide evidence that OmpA-sal activates
TLR signaling pathways in DCs. The recognition of
antigen by TLRs leads to activation of MAPK pathways
in DCs [24]. Therefore, the activation of MAPK by
O m p A - s a li sap o s s i b l em e c hanism underlying the
increased expression of IL-12 by DCs. In this study, we
found that OmpA-sal binds to a TLR4 on DCs and acti-
vates MAPK signaling pathway-mediated IL-12 produc-
tion. DC produces IL-12 and direct activation of CD4-
positive T cells to differentiate into Th1 cells that pro-
duce high levels of IFN-g [25,26]. We confirmed these
results using TLR2
-/- DCs and TLR4
-/- DCs. OmpA-sal
treated TLR2
-/- DCs or TLR4
-/- DCs and then analyzed
IL-12 production by ELISA. We found that OmpA-sal-
treated TLR4-/- DCs had no IL-12 production. These
results suggest that OmpA-sal induced the maturation
and activation of DCs via a TLR4-mediated signaling
pathway.
Conclusions
We demonstrated that OmpA-sal is a potent antigen
and initiates a specific Th1 immune response in vitro.
Further understanding of the mechanism by which
OmpA-sal activates DC maturation and activation may
facilitate the development of effective S. enterica serovar
Typhimurim vaccines and an effective immunotherapeu-
tic adjuvant for other infectious diseases.
Methods
Animals
Male 6-8 week old C57BL/6 (H-2K
b and I-A
b)a n d
BALB/c (H-2K
d and I-A
d) mice were purchased from
the Korean Institute of Chemistry Technology (Daejeon,
Korea).
Reagents and Antibodies
Recombinant mouse (rm)GM-CSF and rmIL-4 were pur-
chased from R&D Systems. Dextran-FITC and LPS (from
Escherichia coli 0 5 5 : B 5 )w e r eo b t a i n e df r o mS i g m a -
Aldrich. An endotoxin filter (END-X) and an endotoxin
Figure 3 OmpA-sal-treated DCs induces proliferation of allogenic T cells and enhanced Th1 resoponse in vitro. The DCs were incubated
for 24 h in medium alone, in 200 ng/ml LPS, or in 400 ng/ml of OmpA-sal. The DC were washed and co-cultured with T cells. Cluster formation
was assessed after 72 h. One representative experiment of three is also included in the figure, showing a representative field in a culture well
photographed using an inverted phase contrast microscope and a mixed lymphocyte reaction was allowed to proceed for 3 days, T-cell
proliferation was analyzed by flow cytometry and presented as a percentage of dividing cells (A). Cells were then examined for cytokine release
after 48 h. IFN-g and IL-4 were measured by ELISA in culture supernatants (B, C). Medium represents the chemically untreated control group.
Similar results were obtained and expressed as the means (±SD) from four separate experiments. **p < 0.01 vs. untreated DCs.
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ates of Cape Cod. Cytokine ELISA kits for murine IL-12
p70, IL-4, IL-10, and IFN-g were purchased from
BD Pharmingen. FITC- or PE-conjugated monoclonal
antibodies (mAbs; BD Pharmingen) were used for flow
cytometry to detect CD11c (HL3), CD80 (16-10A1),
CD86 (GL1), IA
b b-chain (AF-120.1), H2K
b (AF6-88.5),
IL-12 p40/p70 (C15.6), and IL-10 (JESS-16E3). Anti-
phospho-ERK1/2, anti-phospho-p38 MAPK, anti-
phospho-JNK1/2, anti-ERK1/2, anti-JNK1, and anti-p38
MAPK mAb were purchased from Cell signaling. Iso-
type-matched control mAbs and biotinylated anti-CD11c
(N418) mAb were purchased from BD Pharmingen.
Preparation of OmpA-sal
The full-length OmpA-sal gene (X02006.1) was ampli-
fied by PCR, and a chromosomal preparation of
X02006.1 was used as a PCR substrate. The upstream
primer, 5’-GCGGATCCCACGA AGCCGGAGAA-3’,
was designed to carry the EcoRI restriction site. The
downstream primer, 5’-GCAAGCTTAGAAACGA-
TAGCC-3’, carried the HindIII restriction site. PCR pro-
ducts digested with EcoRI and HindIII were ligated into
the pMAL™ expression vector (New England Biolabs
Inc.). E. coli BL21 (DE3)/pMAL™ harboring a ompA-Sal
gene was grown in Luria-Bertani (LB) medium at 37°C.
Recombinant proteins were over-expressed by a bacteria
Figure 4 OmpA-sal induces TLR4 expression, ERK activation, and p38 MAPK activation, but not JNK activation. Total RNA was extracted,
and quantitative real-time PCR was performed using sequence-specific primers for TLR2 and TLR4 (A). Cell lysates were prepared and blotted
with anti-phopho-p38, anti-p38, anti-phopho-ERK1/2, anti-ERK1/2, anti-phopho-JNK1/2, and anti-JNK1 antibody. A signal was detected with
biotinylated goat-anti mouse IgG and visualized using enhanced chemiluminescence (B). DCs, TLR2
-/-DCs, and TLR4
-/-DCs were cultured for 24 h
in the presence of 200 ng/ml of LPS or 400 ng/ml of OmpA-sal and the production levels of IL-12 analyzed by ELISA (C). BM-DCs and TLR4
-/-DCs
were cultured for 24 h in the presence of 400 ng/ml of OmpA-sal and surface markers analyzed by flow cytometry (D). The data are the means
and standard deviation of three experiments. **, P < 0.01 for a compare with untreated DCs.
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endotoxin was ≤0.01 ng/mg.
Generation and culture of DCs
DCs were generated from murine whole bone marrow
(BM) cells. Briefly, the BM was flushed from the tibiae
and femurs of BALB/c mice and depleted of red blood
cells with ammonium chloride. The cells were plated
in 6-well culture plates (10
6 cells/ml) and cultured at
37°C in 5% CO2 and OptiMEM (Invitrogen Life Tech-
nologies) supplemented with 10% heat-inactivated fetal
bovine serum (FBS), 2 mM L-glutamine, 100 U/ml
penicillin, 100 μg/ml streptomycin, 5 × 10
-5 M b-mer-
captoethanol, 10 mM HEPES (pH 7.4), 20 ng/ml
rmGM-CSF, and rmIL-4. On day 3 of culture, floating
cells were gently removed and fresh medium was
added. On day 6 or 7 of culture, non-adherent cells
and loosely adherent proliferating DC aggregates were
harvested for analysis or stimulation, or in some
experiments, replated into 60 mm dishes.
Quantitation of antigen uptake
In brief, DCs were equilibrated at 37°C or 4°C for 45
min, then pulsed with fluorescein-conjugated dextran at
a concentration of 1 mg/ml. Cold staining buffer was
added to stop the reaction. The cells were washed three
times and stained with PE-conjugated anti-CD11c Abs,
then analyzed with the FACSCalibur. Non-specific bind-
ing of dextran to DCs was determined by incubation of
DCs with FITC-conjugated dextran at 4°C and sub-
tracted as background. The medium used in the cultures
with OmpA-sal stimulation was supplemented with
GM-CSF, which is required for the ability of DCs to
capture antigen.
Cytokine assays
Cells were first blocked with 10% (v/v) normal goat
serum for 15 min at 4°C, then stained with FITC-
conjugated CD11c
+ antibody for 30 min at 4°C. Cells
stained with the appropriate isotype-matched Ig were
used as negative controls. The cells were fixed and per-
meabilized with the Cytofix/Cytoperm kit (PharMingen)
according to the manufacturer’s instructions. Intracellu-
lar IL-12p40/p70 and IL-10 were detected with fluores-
cein PE-conjugated antibodies (PharMingen) in a
permeation buffer. The presence of murine IL-12p70,
IL-10, IL-4, and IFN-g in DCs was measured using an
ELISA kit (R&D systems) according to the manufac-
turer’s instructions.
Cytoplasmic extracts and Western blot
The cells were exposed to LPS (200 ng/ml) with or
without OmpA-sal pre-treatment (400 ng/ml). Following
5, 10, 15, or 30 min of incubation at 37°C, cells were
washed twice with cold PBS and lysed with modified
RIPA buffer for 15 min at 4°C. The protein content of
cell lysates was determined using the Micro BCA assay
kit (Pierce, Rockford, IL, USA). Equivalent amounts of
proteins were separated by 10% or 12% SDS-PAGE and
analyzed by Western blotting using anti-phospho-ERK1/
2, anti-phospho-p38 MAPK, anti-phospho-JNK1/2, anti-
ERK1/2, anti-JNK1, and anti-p38 MAPK mAb for 3 h,
as described by the manufacturers.
Mixed lymphocyte reaction
Responder T cells, which participate in allogeneic T-cell
reactions, were isolated from spleens of BALB/c mice
using a MACS column (positive selection sorting).
Staining with FITC-conjugated anti-CD4 Abs revealed
that the recovered cells consisted mainly of CD4
+ cells.
The lymphocyte population was then washed twice in
PBS and labeled with CFSE, as previously described
[28]. The cells were washed once in pure FBS and twice
in PBS with 10% FBS. DCs (1×10
4), or DCs exposed to
OmpA-sal or LPS for 24 h, were co-cultured with 1×10
5
allogeneic CFSE-labeled T lymphocytes in 96-well U-
bottom plates. After 3 days, the CFSE dilution optically-
gated lymphocytes were assessed.
Evaluation of gene expression by real time PCR
TLR 2 and 4 PCR primers were used. Quantitative
amounts of each gene were standardized against the
GAPDH housekeeping gene. Real-time PCR was per-
formed using a BioRad MiniOpticon System (BioRad
Laboratories, Ltd.) with a SYBR green fluorophore.
Reactions were performed in a total volume of 20 μl,
including 10 μlo f2 xS Y B RG r e e nP C RM a s t e rM i x ,1
μl of each primer at 10 ng, and 1 μl of the previously
reverse-transcribed cDNA template. The protocols
used were as follows: denaturation (95°C for 10 min),
and amplification repeated 40 times (95°C for 30 s, 52°
C for 30 s, 72°C for 30 s, and acquisition temperature
for 15 s).
Statistical analysis
All data are expressed as the mean ± standard devia-
tion (SD) and were representative of at least two dif-
ferent experiments. Comparisons between individual
data points were made using the Student’s t-test and
performed using one-way ANOVA analysis (Least Sig-
nificant Difference (LSD) as post-hoc test). Throughout
the figures and legends, the following terminology was
used to denote statistical significance:**, p < 0.01, *,
p < 0.05.
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